At Kizhakkambalam in Ernakulam district of Kerala - among the states that have reported a majority of Covid-19 cases in India - textile manufacturer Kitex Garments is leaving nothing to chance.
The world's second largest manufacturer of children's apparel with 11,000 employees, Kitex has devised a three-pronged defence strategy of modern medicine, homeopathy and ayurveda to keep the virus at bay.
About 8,000 of its employees have been housed in a dormitory block within the factory premises.
Sabu M Jacob, promoter and managing director, explains how they are taking cover from Covid.
Zincovit is being provided to employees in order to boost immunity. There's Arsenicum album as a preventive homeopathic. And finally, a mixture of 12 ayurvedic medicines combined with drinking water as an additional immunity booster.
The firm has also deployed four doctors on campus for health check-ups. The steps appear to be working, as no Covid case has been reported at the factory amid the ongoing surge.
Rising cases have put India Inc on guard fresh advisories on Covid-appropriate behaviour are resurfacing and companies across the board are "closely monitoring" the situation.
A couple of weeks ago, Jindal Steel & Power had issued an advisory to staffers to follow Covid-appropriate behaviour, including wearing masks. Now it's a must at plants and offices.
This story is from the April 17, 2023 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 17, 2023 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
FY25 as weak-earnings year is gradually getting priced in
Even as many blame record foreign portfolio outflows for the market downturn, the real culprit is weak earnings amid rich valuations, says GAUTAM CHHAOCHHARIA, head of global markets, India, UBS. In an interview with Samie Modak in Mumbai ahead of the UBS India Summit, Chhaochharia highlights that 2024-25 (FY25) weak earnings growth is now factoring into market expectations. Investors are shifting their focus to the actions of the Reserve Bank of India (RBI) and the central government, as well as the outcome of upcoming state elections. Edited excerpts:
Non-disclosure of foreign property invites ₹10 lakh penalty per yr
Many high-net-worth individuals who allegedly own undeclared properties in Dubai have received notices from the tax office.
Modest increase in SBI share price after Q2
Brokerages positively revise their earnings forecasts, maintain target price
Strong growth, margin metrics could support LIC's valuations
In the September quarter (Q2FY25), LIC reported net premium income of ₹1.2 trillion, up 12 per cent year-on-year (Y-o-Y).
Mkts settle flat on FPI selling
Benchmark stock indices Sensex and Nifty closed flat in highly volatile trade on Monday as continuous foreign portfolio investors (FPI) selling, disappointing quarterly earnings and weak trends from Asian markets dented investor sentiment.
Rising retail ownership to spur equity cult in India: Morgan Stanley
Retail investors have become a force to reckon with as their ownership of Indian equities has risen by 800 basis points or 8 per cent to 23.4 per cent in the last 10 years, suggests a recent note from Morgan Stanley.
China wrests MSCI EM IMI top spot from India
Change in the pecking order comes amid a sharp rally in Chinese equities
HAVING A TRUCK WITH LNG
Things are changing rapidly with the entry of the private sector, but the path of LNG trucks in India is strewn with rocks
Accounting for climate finance
The climate negotiations meeting of the Conference of Parties signatory to the convention, COP29, at Baku, Azerbaijan, where most nations of the world have gathered currently, shall deal with various concerns relating to climate change.
Re-examine trade pacts
India must consider entering CPTPP, RCEP
